Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.
about
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reductionSerum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study.Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up studyApolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery diseasePrognostic significance of the complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose studyRelation of Combined Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in Adults With Type 1 Diabetes MellitusEstimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adultsBalanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?Reducing vascular events risk in patients with dyslipidaemia: an update for cliniciansApolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular diseaseThe atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females.Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMQuantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemiaNovel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids.Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in Koreans.Blood glucose and insulin and correlation of SLC25A13 mutations with biochemical changes in NICCD patients.Non-high-density lipoprotein cholesterol: An important predictor of stroke and diabetes-related mortality in Japanese elderly diabetic patientsNon-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study
P2860
Q21246041-348988E6-0565-4402-9FA3-6B93BBD108A1Q35081120-8EFFC814-B042-47D4-942D-D4F60AC99011Q35744930-BC702166-FFF2-4FDA-A34E-711262259830Q36023835-BF475FCD-303E-4F86-9ADF-699E2BED8893Q36034940-A05414BF-F8EB-4149-AF81-42B566055DD1Q36054342-2B09DBF1-7211-4B1A-A820-5AA06398A03CQ36281471-A47C2FE6-D5E5-4000-BA03-02D272C2ADD9Q36411656-9AE9A5AC-CFA6-4FFE-8F32-CB78F20FF97DQ36443768-137EB26C-62DC-4D10-A32D-01A3AC0499B0Q36493730-1AD74273-2CCE-497F-AA1B-9308DE020A2CQ36517644-1E8AC00E-4B56-4EB8-B567-427290F9B9D4Q36697855-8D4E0C71-E785-4A54-9CF6-274BC2BA08C2Q37135042-0CF8A397-D91C-480D-89E3-230B9B651F8DQ37683866-17E2287E-460C-4D18-8529-3C60DB98DC44Q41352387-E7ABA1F7-9D81-4E9C-B3C5-373547F2ED26Q44730334-F485D380-48DF-472A-8E3C-4713168D0EBCQ58207412-B64411B9-EFDD-41CD-8056-547B58002A5FQ58731134-D1395EE5-944B-430B-ACFF-74485E9F54F9
P2860
Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@ast
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@en
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@nl
type
label
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@ast
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@en
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@nl
prefLabel
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@ast
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@en
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@nl
P2093
P2860
P356
P1476
Non-HDL-cholesterol as valid s ...... atio and unbiased equivalence.
@en
P2093
Frank M Sacks
Michel F Rousseau
Michel P Hermans
Sylvie A Ahn
P2860
P2888
P356
10.1186/1475-2840-10-20
P407
P577
2011-02-28T00:00:00Z
P5875
P6179
1044134467